Phase I Study of Oral BAY 1217389 in Combination With Intravenous Paclitaxel

Clinical trial NCT02366949 · COMPLETED

Trial details

NCT number: NCT02366949
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Medical Oncology

Start date: 2015-02-27
Primary completion: 2018-03-30
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.